PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.

Significantly longer progression-free survival seen among patients with previously untreated, PD-L1 advanced or metastatic ...

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral ...

HealthDay News — Some canned tuna associated with a 2025 recall has been pulled from grocery stores in 9 states, federal ...

No evidence of association for CWF with birth weight or other birth outcomes in study of >11 million singleton births.

Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

New research on acetaminophen use during pregnancy; the chikungunya vaccine Ixchiq is withdrawn; FDA approves Nexplanon for up to 5 years of use; suicidal ideation warning removed from GLP-1s; at-home ...

More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian ...

South Carolina has reported 646 cases, with numbers rising quickly; most infections involve unvaccinated people.

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions.